Investigator
Agata A Exner
GORDON RESEARCH CONFERENCES · funded by NIBIB
- Companies
- 2
- Grants
- 4
- Non-dilutive funding
- $1.6M
- First award
- Dec 15, 2017
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
Latest May 16, 2026.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- BIOINVISION, INC.73momentum
OncologyGrant-only
- GORDON RESEARCH CONFERENCESMomentum in another area
ImmunologyGrant-only
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- R13
2026 In Vivo Ultrasound Imaging Gordon Research Conference and Gordon Research Seminar
$13kMay 16, 2026NIBIBGORDON RESEARCH CONFERENCESNIH RePORTER · 11388359 (opens the source filing in a new tab)
- R01
Predicting Efficacy of Nanomedicine Based Chemotherapeutics using Contrast Enhanced Ultrasound
$532kApr 23, 2026NIBIBCASE WESTERN RESERVE UNIVERSITYNIH RePORTER · 11296234 (opens the source filing in a new tab)
- R01
Improved Detection of Prostate Cancer with Nanoparticle-based Ultrasound Contrast Agents Targeted to PSMA
$541kDec 15, 2017NIBIBCASE WESTERN RESERVE UNIVERSITYNIH RePORTER · 11031392 (opens the source filing in a new tab)
- R01
Improved Detection of Prostate Cancer with Nanoparticle-based Ultrasound Contrast Agents Targeted to PSMA
$550kDec 15, 2017NIBIBCASE WESTERN RESERVE UNIVERSITYNIH RePORTER · 11259498 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources